People reached
210,000
Completed programme
Malaria, Neglected Tropical Diseases and Child Health
VHT training on rapid diagnostic tests (RDTs), artemisinin-based combination therapy (ACT) distribution, and schistosomiasis MDA
IDI’s implementation role
Regional implementation lead for integrated community case management (iCCM) and mass drug administration (MDA)
Activities
VHT training on rapid diagnostic tests (RDTs), artemisinin-based combination therapy (ACT) distribution, and schistosomiasis MDA
Reach and results
Households and institutions supported
650 Village Health Teams (VHTs), 110 primary schools
Decreased under-five malaria mortality in supported districts by 38%
Programme statistics
iCCM Fever Assessment Accuracy
94.1% of community health workers correctly treated based on mRDT results
MDA Coverage Rate
87.6% therapeutic coverage achieved for schistosomiasis in school-aged children
LLIN Distribution & Utilization
180,000 long-lasting insecticidal nets distributed with an 81.3% household use rate
Severe Malaria Referrals
91% of red-flagged cases successfully transferred to health facilities within 6 hours
Programme enquiries
Discuss this programme, community priorities or opportunities for collaboration.
Detailed programme framework
The sections below retain the programme’s activity explanations, monitoring guidance and planning considerations. Suggested measures and design guidance are distinct from the archive-reported activities and results above.
Programme purpose
Support prevention, early recognition, appropriate referral and disease-control learning at community and facility level.
Community participation, inclusion and reliable evidence would guide programme design and review.
Activity framework
Programme priorities
Community prevention and health education
Community-to-facility referral monitoring
Routine malaria and NTD surveillance data review
Approved implementation research on service delivery
Monitoring and learning
Prevention coverage, referral completion, reporting quality and delays in access to care.
Final indicator definitions and targets would follow programme design and baseline assessment.
Programme development
Planning would establish appropriate expertise, service-provider agreements, safeguarding and data protection. Research and clinical activities would require relevant approvals and qualified providers.
Prepare a programme enquiry